The report forecasts the global neuroendovascular non-coils market to grow at a CAGR of 12.9% during the period 2016-2020.
Flow diversion aneurysm stenting is likely to become one of the widely accepted minimally invasive (MI) procedures for the treatment of an intracranial aneurysm. Physicians' acceptance of flow diverters worldwide led to increased use of other endovascular stents. This shows that flow diversion aneurysm treatment is widely accepted among various medical professionals worldwide, with many hospitals and healthcare centers recommending the procedure to people with carotid artery stenosis.
According to the report, high incidence rates of brain aneurysm and cerebral disorders is one of the major drivers for this market. Brain aneurysm is a common neurological disorder which occurs in 2-6% individuals globally. Cerebral aneurysms are more common in women, and the prevalence of aneurysm increases if a first-degree of relative (i.e., parent, sibling, or child) has an aneurysm. Some of the major causes for cerebral aneurysms include, blood pressure, blood glucose, and lipids. These disorders occur due to unhealthy diet, less physical activity, excessive alcohol consumption, smoking, stress, and obesity and are very common in the age group of 40 years above.
Further, the report states that Currently, the volume of surgeries for the treatment of neuroendovascular diseases is growing at a significant rate owing to rising prevalence, but there is a dearth of skilled neurosurgeons and interventional radiologists with expertise in non-coil neuroendovascular devices. High technical expertise is required to use this equipment effectively to record data and diagnose brain injuries. Only professional surgeons and highly skilled technicians perform these procedures in hospitals, clinics, and trauma centers.